MolecularMatch

Bess and Jake, thank you both for sharing this story. It’s a must read for anyone involved in oncology care or the clinical trial space. We’ve been working nearly ten years at MolecularMatch to improve the searchability of clinical trials and to position clinical trials as a primary care option rather than as a last resort chance at survival. Although we’ve made significant progress in the search experience to find clinical trials, many systemic challenges remain across the clinical trial space to improve patient access to trials. We share the frustration Bess and Jake experienced, and sadly, theirs is one of countless stories on how defeating the entire process is for patients and their families. Although some of the challenges facing these patients are difficult to solve, there are others that can be remedied now. So, what can we do now? 1. Integration between EHR systems, clinical trial coordinators and clinical trial surveillance to improve physician awareness and consideration of clinical trial options throughout a patient’s treatment journey, beginning as soon as a patient is established at an institution. 2. Develop better clinical trial management tools for institutions to locally track, update, improve and enrich the data for both the public and private trials they host so that it’s in one place and easily searchable. 3. Stop waiting for patients to find clinical trials and instead bring best fit trials to the patient through the expansion and exposure of just-in-time trial availability that allows the patient to receive care near their home. Just as we continue to explore new ways to advance care through clinical trials, we hope Jake’s story will motivate everyone involved in patient care to streamline an already arduous journey these patients face.

This type of #thyroidcancer may not require the conventional treatments like radiation, surgery, or chemotherapy. For small papillary thyroid cancer, the process generally includes close monitoring with tests and exams. “The goal of active surveillance or “watchful waiting,” an idea that started to gain traction in the 1990s, is to minimize overtreatment and preserve patients’ quality of life.” https://lnkd.in/ghhS783i

Power your Monday with MolecularMatch! From MMPower to MMPortal, we have you covered so you can provide the best Clinical Intelligence On-Demand for your patients and industry! #oncology #precisionmedicine Learn more at www.molecularmatch.com

Powering up CAR T cells with the keto diet. Researchers have found a significant link between this diet as it's potentially driving these cells to kill off cancer cells. PennMedicine News has more ➡️ bit.ly/3Zsdqsp

With #colorectalcancer as one of the second leading causes of cancer deaths in the US, researchers are finding the link between ultra-processed foods and a higher risk of colorectal cancer. Unhealthy foods and oils are fueling tumor growth and the University of South Florida has more on this research ⬇️ bit.ly/4feZuIb

Find the best solutions with MMPortal and MMPower (API) and get on-demand results with our technology! For nurse navigators, to physicians, and more, we have you covered, so you can provide the best care for your patients! #oncology #precisonmedicine www.molecularmatch.com

Prevention and screening for these cancers have significantly reduced #cancer deaths. Read more about what the 5 cancers are from The National Institutes of Health https://lnkd.in/gYNQwpgV

Here's a look at the latest drug approvals for cancer/hematological malignancies: The #FDA has recently approved: "durvalumab for adults with limited-stage small cell lung cancer (LS-SCLC) whose disease has not progressed following concurrent platinum-based chemotherapy and radiation therapy." bit.ly/3NgMlmo

Reduce your risk of #cancer by following these dos and don’ts from @UCDavisHealth. From quitting tobacco to maintaining good health with exercise, diet, and more. https://lnkd.in/gD59fJsK

Take a look at the latest blog post from The National Institutes of Health regarding how tumor atlases are shedding light on the development of tumors and how they spread. ⬇️ "They map the molecular and cellular features underlying the transformation of precancerous lesions into cancerous tumors and other important cancer transitions." bit.ly/4eYgceB